Inotuzumab ozogamicin and Methylphenidate Controlled-Release Tablets
Determining the interaction of Inotuzumab ozogamicin and Methylphenidate Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Methylphenidate ER Capsules
- Inotuzumab ozogamicin-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Inotuzumab ozogamicin-Methylphenidate Extended-Release Chewable Tablets
- Inotuzumab ozogamicin-Methylphenidate Extended-Release Oral Suspension
- Inotuzumab ozogamicin-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Inotuzumab ozogamicin-Methylphenidate Extended-Release Tablets
- Methylphenidate Controlled-Release Tablets-Inotuzumab ozogamicin Intravenous
- Methylphenidate Controlled-Release Tablets-Inova
- Methylphenidate Controlled-Release Tablets-Inova 4/1 topical
- Methylphenidate Controlled-Release Tablets-Inova 8/2 topical
- Methylphenidate Controlled-Release Tablets-Inova ACT
- Methylphenidate Controlled-Release Tablets-Inrebic